Mason Carrico
Stock Analyst at Stephens
(0.54)
# 4,070
Out of 4,501 analysts
51
Total ratings
36%
Success rate
-5.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTKB Cytek Biosciences | Rated: Buy | $4 → $4.75 | $4.62 | +2.81% | 3 | May 13, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $90 | $88.03 | +2.24% | 1 | Feb 25, 2026 | |
| GKOS Glaukos | Maintained: Buy | $115 → $145 | $152.72 | -5.06% | 2 | Jan 2, 2026 | |
| PACB Pacific Biosciences of California | Maintained: Buy | $2.5 → $2 | $1.56 | +28.21% | 3 | Nov 10, 2025 | |
| NEO NeoGenomics | Maintained: Buy | $18 → $11 | $14.11 | -22.04% | 4 | Sep 2, 2025 | |
| ILMN Illumina | Rated: Buy | $156 → $110 | $190.20 | -42.17% | 8 | Aug 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiated Coverage: Buy | $70 | $20.89 | n/a | 1 | Jul 9, 2025 | |
| MYGN Myriad Genetics | Reiterated: Hold | $24 → $30 | $5.83 | n/a | 5 | Oct 11, 2024 | |
| CDNA CareDx | Maintained: Buy | $15 → $18 | $28.51 | n/a | 7 | May 13, 2024 | |
| TXG 10x Genomics | Reiterated: Buy | $65 | $42.73 | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $23.72 | n/a | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $63 | $160.05 | n/a | 3 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $269.95 | n/a | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $32 | $56.97 | n/a | 4 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.1 → $1.25 | $5.08 | n/a | 2 | May 24, 2022 |
Cytek Biosciences
May 13, 2026
Rated: Buy
Price Target: $4 → $4.75
Current: $4.62
Upside: +2.81%
Establishment Labs Holdings
Feb 25, 2026
Rated: Buy
Price Target: $90
Current: $88.03
Upside: +2.24%
Glaukos
Jan 2, 2026
Maintained: Buy
Price Target: $115 → $145
Current: $152.72
Upside: -5.06%
Pacific Biosciences of California
Nov 10, 2025
Maintained: Buy
Price Target: $2.5 → $2
Current: $1.56
Upside: +28.21%
NeoGenomics
Sep 2, 2025
Maintained: Buy
Price Target: $18 → $11
Current: $14.11
Upside: -22.04%
Illumina
Aug 4, 2025
Rated: Buy
Price Target: $156 → $110
Current: $190.20
Upside: -42.17%
PROCEPT BioRobotics
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $70
Current: $20.89
Upside: n/a
Myriad Genetics
Oct 11, 2024
Reiterated: Hold
Price Target: $24 → $30
Current: $5.83
Upside: n/a
CareDx
May 13, 2024
Maintained: Buy
Price Target: $15 → $18
Current: $28.51
Upside: n/a
10x Genomics
May 18, 2023
Reiterated: Buy
Price Target: $65
Current: $42.73
Upside: n/a
May 8, 2023
Reiterated: Buy
Price Target: $41
Current: $23.72
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: $90 → $63
Current: $160.05
Upside: n/a
Dec 16, 2022
Maintained: Buy
Price Target: n/a
Current: $269.95
Upside: n/a
Dec 5, 2022
Reiterated: Buy
Price Target: $30 → $32
Current: $56.97
Upside: n/a
May 24, 2022
Downgraded: Hold
Price Target: $3.1 → $1.25
Current: $5.08
Upside: n/a